-
Founded in:
1997-10-27 -
Country:
China -
Address:
No. 1, Wangjiashan Road, Qingshanhu Street, Lin'an District, Hangzhou City, Zhejiang Province -
Tax NO.:
91330185253932420N -
Registered Funds:
56.5 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cytochrome C |
It is a protein with iron porphyrin as a cofactor that exists in the mitochondria of cells. It is arranged in a certain order to form a cytochrome system. The Fe3 in the molecule can undergo a reversible redox reaction under the action of related enzymes, and is responsible for the transfer of electrons, which is indispensable for cell respiration. When tissues are hypoxic, exogenous agents can enter the cells and play a role in correcting cell respiration and material metabolism.
More
It is a protein with iron porphyrin as a cofactor that exists in the mitochondria of cells. It is arranged in a certain order to form a cytochrome system. The Fe3 in the molecule can undergo a reversible redox reaction under the action of related enzymes, and is responsible for the transfer of electrons, which is indispensable for cell respiration. When tissues are hypoxic, exogenous agents can enter the cells and play a role in correcting cell respiration and material metabolism. |
9007-43-6 | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Irsogladine maleate |
This product is a gastric mucosal protective agent. It strengthens the combination between gastric mucosal epithelial cells, inhibits the peeling and shedding of epithelial cells and the expansion of cell gaps, enhances the stability of mucosal cells themselves, plays a mucosal defense role, and inhibits harmful substances from passing through the mucosa. Its mechanism of action is related to increasing the content of CAMP, prostaglandins, reduced glutathione and mucus glycoprotein in gastric mucosal cells. Experiments show that this product can inhibit gastric mucosal cell disorders caused by hydrochloric acid and ethanol, and also has the effect of increasing gastric mucosal blood flow. The effect is dose-dependent.
More
This product is a gastric mucosal protective agent. It strengthens the combination between gastric mucosal epithelial cells, inhibits the peeling and shedding of epithelial cells and the expansion of cell gaps, enhances the stability of mucosal cells themselves, plays a mucosal defense role, and inhibits harmful substances from passing through the mucosa. Its mechanism of action is related to increasing the content of CAMP, prostaglandins, reduced glutathione and mucus glycoprotein in gastric mucosal cells. Experiments show that this product can inhibit gastric mucosal cell disorders caused by hydrochloric acid and ethanol, and also has the effect of increasing gastric mucosal blood flow. The effect is dose-dependent. |
84504-69-8 | 5 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 1,1-DIMETHYLBIGUANIDE HYDROCHLORIDE |
This product is a hypoglycemic drug that can reduce fasting and postprandial hyperglycemia in patients with type 2 diabetes, and can reduce HbAlc by 1% to 2%. Its mechanism of lowering blood sugar is: 1. Increase the sensitivity of peripheral tissues to insulin and increase insulin-mediated glucose utilization. 2. Increase the utilization of glucose by non-insulin-dependent tissues, such as the brain, blood cells, renal medulla, intestines, skin, etc. 3. Inhibit hepatic gluconeogenesis and reduce hepatic glucose output. 4. Inhibit intestinal wall cells from taking up glucose. Unlike the action of insulin, this product has no effect on promoting fat synthesis, has no obvious hypoglycemic effect on normal people, and generally does not cause hypoglycemia when used alone for type 2 diabetes.
More
This product is a hypoglycemic drug that can reduce fasting and postprandial hyperglycemia in patients with type 2 diabetes, and can reduce HbAlc by 1% to 2%. Its mechanism of lowering blood sugar is: 1. Increase the sensitivity of peripheral tissues to insulin and increase insulin-mediated glucose utilization. 2. Increase the utilization of glucose by non-insulin-dependent tissues, such as the brain, blood cells, renal medulla, intestines, skin, etc. 3. Inhibit hepatic gluconeogenesis and reduce hepatic glucose output. 4. Inhibit intestinal wall cells from taking up glucose. Unlike the action of insulin, this product has no effect on promoting fat synthesis, has no obvious hypoglycemic effect on normal people, and generally does not cause hypoglycemia when used alone for type 2 diabetes. |
15537-72-1 | 55 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Coenzyme Q10 |
This product has the function of promoting oxidative phosphorylation reaction and protecting the integrity of biological membrane structure. It is a fat-soluble quinone compound widely present in organisms, plays an important role in proton translocation and electron transfer in the respiratory chain in the body, is an activator of cell respiration and cell metabolism, and is also an important antioxidant and non-specific immune enhancer.
More
This product has the function of promoting oxidative phosphorylation reaction and protecting the integrity of biological membrane structure. It is a fat-soluble quinone compound widely present in organisms, plays an important role in proton translocation and electron transfer in the respiratory chain in the body, is an activator of cell respiration and cell metabolism, and is also an important antioxidant and non-specific immune enhancer. |
303-98-0 | 14 |